CytoDyn Inc. (OTCMKTS:CYDY) Sees Significant Growth in Short Interest

CytoDyn Inc. (OTCMKTS:CYDY) was the recipient of a significant increase in short interest in December. As of December 31st, there was short interest totalling 20,123,400 shares, an increase of 15.0% from the December 15th total of 17,499,100 shares. Based on an average daily trading volume, of 6,176,200 shares, the days-to-cover ratio is presently 3.3 days.

CytoDyn Trading Up 1.3 %

CytoDyn stock traded up $0.00 during mid-day trading on Friday, reaching $0.15. The company had a trading volume of 1,217,001 shares, compared to its average volume of 2,325,929. The stock’s 50-day simple moving average is $0.12 and its 200-day simple moving average is $0.14. CytoDyn has a 1 year low of $0.10 and a 1 year high of $0.32.

CytoDyn Company Profile

CytoDyn Inc, a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer.